Travere Therapeutics (TVTX) Tops Q1 EPS by 36c
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Join SI Premium – FREE
Travere Therapeutics (NASDAQ: TVTX) reported Q1 EPS of ($0.19), $0.36 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $81.73 million versus the consensus estimate of $78.05 million.
For earnings history and earnings-related data on Travere Therapeutics (TVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Momo (MOMO) Tops Q2 EPS by 8c; offers guidance
- Jefferies Starts Centrus Energy Corp. (LEU) at Hold
- Goldman Sachs Reiterates Buy Rating on HP Enterprise (HPE)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
